Beaumont Financial Partners, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Beaumont Financial Partners, LLC
- $1.04 Billion
- Q3 2022
A detailed history of Beaumont Financial Partners, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 11,000 shares of DNA stock, worth $89,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,000
Previous 10,000
10.0%
Holding current value
$89,430
Previous $24,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DNA
# of Institutions
343Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.16 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.13 Billion0.0% of portfolio
-
Baillie Gifford & CO134MShares$1.09 Billion0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$568 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$342 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $10.5B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...